Analyst Ratings for Monte Rosa Therapeutics (GLUE)
GLUE Rating Summary
GLUE Price Target Summary
- Highest: $40.00 (Jefferies)
- Lowest: $26.00 (Wedbush)
- Average: $32.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$32.00 (+123.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$32.00 (+123.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
14.78 (14.31) |
-3.18% | Details |
| 12/16/2025 | Wells Fargo » Updated 8/7/2026 |
Derek Archila | Upgrade | Overweight (Equal Weight) |
27.00 (29.00) |
16.45 (14.31) |
-13.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
